Correspondence 0001213900-24-059065 from CERO THERAPEUTICS HOLDINGS, INC. (CERO)
CERO THERAPEUTICS HOLDINGS, INC.
Date: July 3, 2024 · CIK: 0001870404 · Accession: 0001213900-24-059065
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-279156
Letter
VIA EDGAR Division of Corporation Finance Office of Life Sciences Acceleration Request for Registration Statement on Form S-1 File No. 333-279156 Requested Date: July 5, 2024 Requested Time: 4:30 p.m. Eastern Time
Dear Ladies and Gentleman,
Pursuant to Rule 461 under the Securities Act of 1933, as amended, CERo Therapeutics Holdings, Inc. hereby requests that the effective date of the above-referenced registration statement (the “Registration Statement”) be accelerated to July 5, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as practicable, unless we or our outside counsel, Goodwin Procter LLP (“Goodwin”), request by telephone that such Registration Statement be declared effective at some other time.
Once the Registration Statement is effective, please orally confirm the event with our counsel, Goodwin, by calling Stephen Davis at (212) 813-8804. We also respectfully request that a copy of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be sent to our counsel, Goodwin, Attention: Stephen Davis, by email at SDavis@goodwinlaw.com.
If you have any questions regarding this request, please contact Stephen Davis of Goodwin at (212) 813-8804.
Sincerely,
CERo Therapeutics Holdings, Inc.
Show Raw Text
CORRESP
1
filename1.htm
CERo Therapeutics Holdings, Inc.
201 Haskins Way, Suite 230
South San Francisco, CA 94080
July 3, 2024
VIA EDGAR
Division of Corporation Finance
Office of Life Sciences
U.S. Securities and Exchange Commission
100 F Street, N.E.
Washington, D.C. 20549
Re: CERo Therapeutics Holdings, Inc.
Acceleration Request for Registration Statement
on Form S-1
File No. 333-279156
Requested Date: July 5, 2024
Requested Time: 4:30 p.m. Eastern Time
Dear Ladies and Gentleman,
Pursuant to Rule 461 under the Securities Act of
1933, as amended, CERo Therapeutics Holdings, Inc. hereby requests that the effective date of the above-referenced registration statement
(the “Registration Statement”) be accelerated to July 5, 2024, at 4:30 p.m., Eastern Time, or as soon thereafter as
practicable, unless we or our outside counsel, Goodwin Procter LLP (“Goodwin”), request by telephone that such Registration
Statement be declared effective at some other time.
Once the Registration Statement is effective, please
orally confirm the event with our counsel, Goodwin, by calling Stephen Davis at (212) 813-8804. We also respectfully request that a copy
of the written order from the Securities and Exchange Commission verifying the effective time and date of the Registration Statement be
sent to our counsel, Goodwin, Attention: Stephen Davis, by email at SDavis@goodwinlaw.com.
If you have any questions regarding this request,
please contact Stephen Davis of Goodwin at (212) 813-8804.
Sincerely,
CERo Therapeutics Holdings, Inc.
/s/ Brian G. Atwood
Chief Executive Officer
cc: Stephen M. Davis, Esq., Goodwin Procter LLP
Jeffrey A. Letalien, Esq., Goodwin Procter LLP